Overview

Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial

Status:
Active, not recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Steadman Philippon Research Institute

Collaborators:

Office of Naval Research (ONR)
United States Department of Defense